The global animal vaccines market size is expected to reach USD 31.07 billion by 2032, expected to grow at a CAGR of 9.90% during the forecast period.
The Animal Vaccines Market is an essential segment of the global veterinary healthcare industry, focusing on the development, production, and distribution of vaccines used to prevent infectious diseases in animals. These vaccines are crucial for both pets and livestock, ensuring animal health and preventing the spread of diseases that could impact animal populations, food security, and public health. The market includes vaccines for both companion animals (such as dogs, cats, and horses) and livestock (such as cattle, poultry, and swine).
Market Growth Drivers
- Increasing Incidence of Zoonotic Diseases: With the rising frequency of diseases that can be transmitted from animals to humans (such as avian flu, rabies, and COVID-19), the demand for effective animal vaccines is growing. Vaccination of animals helps in preventing the transmission of these diseases to humans.
- Rising Animal Disease Outbreaks: The frequent outbreaks of animal diseases, such as Foot-and-Mouth Disease (FMD), African Swine Fever (ASF), and Newcastle Disease, have heightened the need for robust vaccination programs to safeguard animal health and ensure food safety.
- Growing Livestock Industry: As the global demand for animal-derived food products (such as meat, dairy, and eggs) increases, there is greater emphasis on preventing diseases in livestock to maintain food security and the profitability of farming.
Some of the major players operating in the global market include:
- Biogénesis Bagó
- Boehringer Ingelheim International GmbH
- Elanco
- Merck & Co. Inc.
- Ceva
- Intas Pharmaceuticals Ltd.
- Indian Immunologicals Ltd.
- Neogen Corporation
- Phibro Animal Health Corporation
- Ourofino Saúde Animal
- Virbac
- Zoetis.
Download Free Sample PDF Copy of the Report:
https://www.polarismarketresearch.com/industry-analysis/animal-vaccines-market/request-for-sample
Key Trends
- Advancement of DNA and mRNA Vaccines: The development of DNA and mRNA vaccines for animals is gaining momentum, particularly due to their potential for faster production and ability to generate immune responses without the use of live pathogens. These innovative vaccines have the potential to revolutionize the animal vaccination landscape.
- Increased Focus on Livestock Vaccination: There is a growing emphasis on livestock vaccines to prevent diseases such as avian influenza, rabies in livestock, and bovine tuberculosis. Livestock vaccination is increasingly viewed as an important tool for improving global food security and animal health.
- Oral and Injectable Vaccine Options: Oral vaccines, particularly for livestock, are being developed as a more convenient and efficient option, reducing the need for injections and improving vaccination coverage in large animal populations.
Recent Developments
- In June 2021, the United Kingdom announced plans to open a U.K. Animal Vaccine Production and Innovation Centre in Surrey. This facility aims to speed up the development of livestock vaccines and stop the spread of viral illnesses like coronavirus.
- In September 2022 the second phase of the National Animal Disease Control Programme for vaccination against Foot and Mouth Disease was formally begun by the Nagaland Livestock Development Board (NLDB), which oversees the animal husbandry department and veterinary services in Nagaland.
- In September 2021, Virbac and Jectas innovators entered into a collaboration to develop animal health vaccines.
- In February 2021, A first framework agreement between CevaSanté Animale and INRAE was signed to strengthen their veterinary health collaboration. It also involves testing vaccinations and anti-infective medications, as well as several other forms of collaboration.
𝐒𝐞𝐠𝐦𝐞𝐧𝐭𝐚𝐥 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰:
The research report categorizes the market into various segments and sub-segments. The primary segments covered in the study include type, application, end use and region. The splitting of the market into various groups enables businesses to understand market preferences and trends better. Also, stakeholders can develop products/services that align with the diverse needs of consumers in the industry. Besides, the research study includes a thorough examination of all the major sub-segments in the market.
Animal Vaccines Market, Products Outlook (Revenue – USD Billion, 2019 – 2032)
- Attenuated Live Vaccines
- Conjugate Vaccines
- Inactivated Vaccines
- Subunit Vaccines
- Toxoid Vaccines
- DNA Vaccines
- Recombinant Vaccines
Animal Vaccines Market, Type Outlook (Revenue – USD Billion, 2019 – 2032)
- Poultry
- Aqua
- Companion
- Canine
- Feline
- Avian
- Equine
- Bovine
Animal Vaccines Market, Disease Outlook (Revenue – USD Billion, 2019- 2032)
- Swine Pneumonia
- Avian Influenza
- Rabies
- Coccidiosis
- Brucellosis
- Distemper
- Canine
- Foot & Mouth
- Strangles
Animal Vaccines Market, Route of Administration Outlook (Revenue – USD Billion, 2019- 2032)
- Subcutaneous
- Intramuscular
- Intranasal
The Animal Vaccines Market is expected to witness strong growth driven by rising concerns about zoonotic diseases, advancements in vaccine technology, and the increasing need for disease prevention in both companion animals and livestock. As the global demand for animal-derived food products rises, so does the importance of ensuring the health and productivity of livestock populations through vaccination programs.
More Trending Latest Reports By Polaris Market Research:
Identity Threat Detection and Response (ITDR) Market